‘Misbranded’ Abhayrab rabies vaccine seized in Delhi, ‘no part exported to any other country’: What DCGI said
The Delhi Police Crime Branch, along with the Delhi Drugs Control Department, seized a batch of the Abhayrab vaccine (batch number KE25012), which was declared misbranded and not of Standard Quality by the Central Drugs Laboratory (CDL), Kasauli.
Four individuals were apprehended after authorities discovered a batch of improperly labeled Abhayrab rabies vaccine during a search of an unlicensed location in Delhi on April 22, 2026, as announced by the Drugs Controller General of India (DCGI). This incident marks the second instance within a two-year period concerning counterfeit Abhayrab vaccines in India.The regulator expressed concerns over the sample's identity and authenticity, indicating the need for further investigation to determine if the vaccine was counterfeit under India's Drugs and Cosmetics Act.
The Delhi Police Crime Branch and the Delhi Drugs Control Department seized a batch of the Abhayrab vaccine (batch number KE25012) from an unauthorized premises, which was subsequently declared misbranded and non-standard quality by the Central Drugs Laboratory (CDL) in Kasauli. The CDSCO was subsequently called to the scene for legal sampling, after which the samples were sent to the CDL for examination.
The manufacturer, Indian Immunologicals Ltd (IIL), affirmed that genuine Abhayrab vaccines are only released post-independently tested and government batch-release certification.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
